Skip to main content
OpenTrials
Completed

NCT Number: NCT05261984

Investigating the Anabolic Response to Resistance Exercise After Critical Illness (ARTIST-2)

ICU survivors often suffer from long-term functional disability. An attenuated response to physical exercise in skeletal muscle after critical illness may contribute to persisting weakness.

The aim of this study is to investigate the effects of resistance exercise on muscle protein synthesis in former ICU patients. The investigators hypothesize that study subjects recovering from critical illness have an impaired anabolic response to resistance exercise after ICU stay as compared to non-critically ill controls.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Karolinska University Hospital

Huddinge, Stockholm County, 14186, Sweden

About this study

Background

The debilitating impact of critical illness has been recognized for several decades. Disability related to intensive care is now described as a syndrome called ICU-acquired weakness (ICUAW). ICUAW affects up to 70% of ICU patients and is most common with higher illness severity. Patients that develop ICUAW require longer hospitalization and have a higher risk of death. Weakness may persists for several years in ICU survivors. It has significant long-term consequences, and is associated with increased health care costs, delayed return to work, and overall poor quality of life.

Muscle atrophy is a major contributor to ICUAW. Critical illness is associated with a rapid loss of skeletal muscle, induced by catabolic signals from proinflammatory cytokines and hormones. The ability to regain lost muscle mass during convalescence may also be impaired. In a small observational study, muscle atrophy resolved only in a minority of ICU survivors at six months after ICU discharge.

Studies in exercise physiology have demonstrated that resistance training and amino acid ingestion have synergistic effects on muscle protein synthesis in healthy subjects. It is therefore an appealing therapy to reconstitute muscle mass after critical illness. Despite several clinical trials, there is equipoise regarding the efficacy of exercise in improving physical function in-ICU after ICU discharge. These mixed signals are unsurprising given the heterogeneous causes of ICUAW.

Only a few studies in this field have examined muscle architecture or cellular signaling in response to training. However, the gold standard in determining the anabolic response to exercise is to directly measure the effects on protein synthesis and breakdown. There is still no published research using this methodology to assess the effects of exercise interventions in former ICU patients. To understand the role of physical exercise in regaining lost muscle mass, the investigators plan to investigate the anabolic effects to resistance training after critical illness.

Aim and hypothesis

The aim of this study is to determine the anabolic response to resistance exercise after critical illness. The investigators hypothesize that study subjects recovering from critical illness have an impaired anabolic response to resistance exercise after ICU stay as compared to non-critically ill controls.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult (≥18 years) previously admitted to an ICU at Karolinska University Hospital for ≥3 days and discharged alive from hospital

OR

  • Adult (≥18 years) without a history of ICU admission (control group)

Exclusion criteria

  • Not able to provide informed consent
  • >6 months since ICU discharge*
  • Warfarin or dual antiplatelet therapy
  • Clinically significant inherited or acquired disorder of hemostasis
  • Lower-limb amputee
  • Lower-limb atherosclerotic disease with critical ischemia.
  • Recent fracture in lower limbs or significant osteoarthritis limiting movement in knee or hip joint
  • Metastatic cancer or active hematological malignancy
  • Inherited disorder of amino acid metabolism.
  • Chronic muscle, neuromuscular or neurologic disease with prior documentation of clinically significant lower-limb involvement
  • Pregnancy
  • Single organ failure not requiring invasive mechanical ventilation during ICU stay*
  • Intubated only for airway protection with no other organ failure(s) during ICU stay*
  • Planned postoperative care in ICU after elective cardiothoracic surgery*

Exclusion criteria

marked with asterisk only apply to former ICU patients.

Treatment and study plan

Resistance Exercise

Procedure

Knee extensions in flywheel inertia machine in four sets of 10 repetitions.

Oral protein supplementation

Dietary Supplement

24 grams of hydrolyzed whey protein.

Primary outcomes

  1. Muscle protein fractional synthetic rate

    Time frame: 150 minutes post-exercise.

    The difference between the experimental and active comparator group in muscle protein fractional synthetic rate.

Secondary outcomes

  1. Gene expression

    Time frame: 150 minutes post-exercise.

    The difference between the experimental and active comparator group in gene expression (mRNA) in skeletal muscle, assessed by RNA sequencing.

  2. Signaling pathways

    Time frame: 150 minutes post-exercise.

    The difference between the experimental and active comparator group in the activity of major anabolic/catabolic signalining pathways in skeletal muscle, assessed by western blot.

Sponsors and collaborators

Lead sponsor

Karolinska University Hospital

Other

Registry information

Official study title

Investigating the Anabolic Response to Resistance Exercise After Critical Illness: The ARTIST-2 Non-Randomized Controlled Trial

Acronym: ARTIST-2

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Mar 2, 2022
Registry last updated
Feb 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.